Biofrontera Inc (NASDAQ:BFRI) has a beta value of 0.38 and has seen 7.58 million shares traded in the last trading session. The company, currently valued at $7.73M, closed the last trade at $0.87 per share which meant it gained $0.11 on the day or 14.62% during that session. The BFRI stock price is -364.37% off its 52-week high price of $4.04 and 29.89% above the 52-week low of $0.61. If we look at the company’s 10-day average daily trading volume, we find that it stood at 1.22 million shares traded. The 3-month trading volume is 2.56 million shares.
The consensus among analysts is that Biofrontera Inc (BFRI) is Buy stock at the moment, with a recommendation rating of 1.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 2 have rated it as a Hold, with 2 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -0.07.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Biofrontera Inc (NASDAQ:BFRI) trade information
Sporting 14.62% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the BFRI stock price touched $0.87 or saw a rise of 6.45%. Year-to-date, Biofrontera Inc shares have moved -68.59%, while the 5-day performance has seen it change 18.53%. Over the past 30 days, the shares of Biofrontera Inc (NASDAQ:BFRI) have changed -10.31%. Short interest in the company has seen 0.46 million shares shorted with days to cover at 0.08.
Biofrontera Inc (BFRI) estimates and forecasts
Figures show that Biofrontera Inc shares have outperformed across the wider relevant industry. The company’s shares have lost -17.14% over the past 6 months, with this year growth rate of 81.39%, compared to 18.00% for the industry. Revenue growth from the last financial year stood is estimated to be 15.38%.
2 analysts offering their estimates for the company have set an average revenue estimate of 14.53M for the current quarter. 2 have an estimated revenue figure of 11.5M for the next ending quarter. Year-ago sales stood 10.6M and 7.91M respectively for this quarter and the next, and analysts expect sales will grow by 37.13% for the current quarter and 15.38% for the next.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 7.90% over the past 5 years.
BFRI Dividends
Biofrontera Inc is expected to release its next earnings report in December this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Biofrontera Inc (NASDAQ:BFRI)’s Major holders
Insiders own 32.06% of the company shares, while shares held by institutions stand at 20.68% with a share float percentage of 30.44%. Investors are also buoyed by the number of investors in a company, with Biofrontera Inc having a total of 12.0 institutions that hold shares in the company.
Also the top two Mutual Funds that are holding company’s shares are Fidelity Extended Market Index Fund and Vanguard Extended Market Index Fund . As of Sep 30, 2024 , the former fund manager holds about 0.20% shares in the company for having 15.14 shares of worth $13170.0 while later fund manager owns 8.61 shares of worth $7491.0 as of Jun 30, 2024 , which makes it owner of about 0.11% of company’s outstanding stock.
